Regeneron Announces Presentation at the 32nd Annual J. P. Morgan Healthcare Conference

TARRYTOWN, N.Y., Dec. 17, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the 32nd Annual J. P. Morgan Healthcare Conference on Tuesday, January 14, 2014.  The presentation is scheduled for 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time) and may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page.  An archived version of the presentation will be available for 30 days.

About Regeneron Pharmaceuticals
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis.  For additional information about the company, please visit www.regeneron.com.

Contact Information:                                   

Manisha Narasimhan, Ph.D.

Peter Dworkin

Investor Relations

Corporate Communications                           

914.847.5126

914.847.7640             

manisha.narasimhan@regeneron.com

peter.dworkin@regeneron.com

 

SOURCE Regeneron Pharmaceuticals, Inc.



RELATED LINKS
http://www.regeneron.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.